Valuation: CellaVision AB

Market Cap 477.03Cr 49Cr 43Cr 40Cr 36Cr 69Cr 4.55TCr 70Cr 190.13Cr 2.44TCr 182.23Cr 178.33Cr 7.67TCr P/E 2026 *
33x
P/E 2027 * 25.6x
Enterprise Value 457.15Cr 47Cr 42Cr 38Cr 35Cr 66Cr 4.36TCr 67Cr 182.21Cr 2.33TCr 174.63Cr 170.9Cr 7.35TCr EV / Sales 2026 *
5.8x
EV / Sales 2027 * 5.11x
Free-Float
81.06%
Yield 2026 *
1.38%
Yield 2027 * 1.6%
1 day+2.00%
1 week+6.54%
Current month+4.04%
1 month+24.69%
3 months+33.53%
6 months+69.30%
Current year+29.45%
1 week 189.2
Extreme 189.2
205
1 month 160.6
Extreme 160.6
205
Current year 117.6
Extreme 117.6
205
1 year 117.6
Extreme 117.6
205
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
399.2
10 years 77.75
Extreme 77.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Buy

Chief Executive Officer

8,077 0.0339%
02/09/26 Free 1,00,000 0.4193%
28/04/26 Don

Founder

76,434 0.3205%
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%+6.54%+27.19%+29.95% 49Cr
-0.54%+2.70%+24.43%+59.93% 27TCr
-0.47%+1.37%+10.46%+18.41% 17TCr
-1.67%+2.62%-21.50%+63.00% 16TCr
-0.40%+0.57%-56.64%-15.15% 6.38TCr
-1.48%+8.52%+22.86%+60.88% 6.02TCr
-0.38%-0.76%-0.78%-9.64% 5.38TCr
-1.31%+1.17%+21.29%+63.66% 5.08TCr
-0.64%+1.29%+3.85%+86.05% 4.96TCr
-1.24%+2.25%+24.88%+83.76% 4.68TCr
Average -0.58%+3.91%+5.60%+44.08% 9TCr
Weighted average by Cap. -0.83%+4.38%+5.45%+46.56%

Financials

2026 *2027 *
Net sales 79Cr 8.02Cr 7.16Cr 6.58Cr 5.98Cr 11Cr 751.36Cr 12Cr 31Cr 402.25Cr 30Cr 29Cr 1.27TCr 88Cr 9Cr 8.03Cr 7.39Cr 6.71Cr 13Cr 843.19Cr 13Cr 35Cr 451.42Cr 34Cr 33Cr 1.42TCr
Net income 14Cr 1.47Cr 1.31Cr 1.21Cr 1.1Cr 2.08Cr 138.03Cr 2.13Cr 5.77Cr 74Cr 5.53Cr 5.41Cr 232.75Cr 19Cr 1.9Cr 1.7Cr 1.56Cr 1.42Cr 2.68Cr 178.05Cr 2.75Cr 7.44Cr 95Cr 7.13Cr 6.98Cr 300.23Cr
Net Debt -20Cr -2.02Cr -1.81Cr -1.66Cr -1.51Cr -2.86Cr -189.7Cr -2.93Cr -7.93Cr -101.56Cr -7.6Cr -7.43Cr -319.86Cr -25Cr -2.57Cr -2.29Cr -2.11Cr -1.91Cr -3.63Cr -240.66Cr -3.72Cr -10Cr -128.84Cr -9.64Cr -9.43Cr -405.8Cr
Projected Income Statement - Annual - CellaVision AB
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
252
Date Price Change Volume
10/26/10 SEK 203.00 +1.50% 51,940
09/26/09 SEK 200.00 +0.50% 1,01,211
06/26/06 SEK 199.00 +0.51% 1,01,652
05/26/05 SEK 198.00 -0.90% 45,583
04/26/04 SEK 199.80 +4.61% 80,842
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - CellaVision AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
200.00SEK
Average target price
198.33SEK
Spread / Average Target
-0.83%
  1. Stock Market
  2. Stocks
  3. CEVI Stock